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Brain glutamate and y-aminobutyrate (GABA) metabolism in 
thiamin-deficient rats 
BY MARTYN G. PAGE*, VICTOR ANKOMA-SEYt,  WILLIAM F. COULSON 
A N D  DAVID A. BENDERS 
Department of Biochemistry, University College and Middlesex School of Medicine, 
University College London, Gower Street, London W C l E  6BT 
(Received 2 February 1989 - Accepted 29 March 1989) 
The brain metabolism of glutamate and y-aminobutyrate (GABA) was investigated in thiamin-deficient 
and pair-fed control rats, in order to determine whether the GABA shunt may provide an important 
alternative to 2-0x0-glutarate dehydrogenase (EC 1 .2.4.2) in energy-yielding metabolism in thiamin 
deficiency. Brains from thiamin-deficient animals contained less glutamate, 2-0x0-glutarate and GABA 
than those from control animals. The brain content of ATP was unaffected by thiamin deficiency. After 
intracerebroventricular injection of ['4C]glutamate, the specific radioactivity of GABA in the brains from 
deficient animals was 45-50% higher than that in controls, suggesting a considerable increase in the 
metabolic flux through the GABA shunt in thiamin deficiency. Brain GABA showed a marked 
circumannual variation, with a peak in mid-summer and a minimum value in mid-winter. 
y-Aminobutyrate: Brain glutamate: GABA: Thiamin deficiency : Rat 
Thiamin has a central role in energy-yielding metabolism. Thiamin pyrophosphate is 
the coenzyme for pyruvate dehydrogenase (EC 1 .2.4. I), 2-0x0-glutarate dehydrogenase 
(EC 1 .2.4.2) and transketolase (EC 2.2.1 . I), and hence thiamin deficiency results in a 
considerable impairment of both carbohydrate metabolism, by way of glycolysis and the 
pentose phosphate pathway, and general energy-yielding metabolism, by way of the citric 
acid cycle (Holowack et al. 1968; Collins et al. 1970). Deficiency affects especially the 
nervous system, which is largely dependent on glucose metabolism. In the Far East, chronic 
thiamin insufficiency results in peripheral nervous system damage, dry beriberi, whereas in 
Western countries thiamin deficiency (associated with alcohol and opiate abuse) results in 
central nervous system damage, the Wernicke-Korsakoff syndrome. 
Both the time course of the development of neurological signs and the anatomical 
location of brain lesions in thiamin-deficient experimental animals are poorly correlated 
with the impairment of pyruvate dehydrogenase, and show a better correlation with 
impairment of transketolase (Dreyfus & Hauser, 1965). However, there is a considerable 
excess of transketolase activity compared with other enzymes of the pentose phosphate 
pathway, and it is unlikely that even under conditions of severe thiamin deficiency that 
transketolase would be a rate-limiting step in carbohydrate metabolism (McCandless et al. 
1976). 
Despite the impairment of energy-yielding metabolism, there is no change in the brain 
content of ATP in thiamin deficiency (Holowack et al. 1968; McCandless & Schenker, 
1968). While this might reflect simply an excess of 2-0x0-glutarate dehydrogenase activity, 
as is the case for transketolase, it is also possible that there may be an alternative pathway 
for the conversion of 2-0x0-glutarate to succinate. 
Present addresses : * St Joseph's College, Oxford OX4 2UJ. t Ghana Medical School, Korle Bu, Accra, Ghana. 
$ For reprints. 
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Fig. 1. The GABA shunt and tricarboxylic acid cycle. (a), 2-0x0-glutarate dehydrogenase (EC 1.2.4.2); (b), 
GABA aminotransferase (EC 2.6.1.19) and other aminotransferases, glutamate dehydrogenase (EC 1.4.1.2); 
(c), glutamate decarboxylase (EC 4 . 1  . I  .15) ; (d), succinic semi-aldehyde dehydrogenase (EC 1 .2.1.24). 
The neurotransmitter y-aminobutyrate (GABA) is synthesized by decarboxylation of 
glutamate (which arises by transamination or reductive amination of 2-oxo-glutarate), and 
is in turn catabolized by transamination to succinic semialdehyde and oxidation to 
succinate. This pathway (shown in Fig. 1) has been termed the GABA shunt; in addition 
to its role in synthesizing and catabolizing the neurotransmitter, it is possible that the 
GABA shunt plays a role in energy-yielding metabolism. 
The present study was designed in order to determine whether the GABA shunt may 
provide a significant alternative to 2-0x0-glutarate dehydrogenase in thiamin deficiency, 
by-passing this thiamin-dependent step in the tricarboxylic acid cycle. 
M E T H O D S  
Animals and diets 
Male Wistar rats were maintained for up to 4 weeks from weaning on a high-carbohydrate, 
thiamin-free diet containing (g/kg) : maize starch 547, sucrose 200, vitamin-free casein 140, 
gelatine 60, mineral salt mix 41, maize oil 10 and vitamin mix 2. Vitamins A, D, E and K 
were dissolved in the maize oil, to provide (mg/kg diet): retinol palmitate 10, calciferol 
3 pg, menaphthone 1 and a-tocopheryl acetate 75. The vitamin mixture provided (mg/kg 
diet): riboflavin 10, nicolinamide 15, pyridoxine hydrochloride 5, biotin 1, folic acid 5, 
vitamin B,, 50 pg, calcium pantothenate 40, choline bitartrate 1800. The mineral salt 
mixture provided (g/kg diet): CaHPO, 18.1, KCl 8.2, Na,HPO, 7.4, CaCO, 4.5, 
MgSO, . H,O 2.8, ZnCO, 30 mg, CuSO, .5H,O 23.5 mg, MnSO, .4H,O 18 mg, ferric citrate 
pentahydrate 18 mg, KIO, 1 mg. The dry ingredients, except the gelatin, were mixed 
together with the maize oil, then the gelatine was dissolved in 600 ml hot water/kg diet and 
mixed with the dry ingredients. On cooling, the diet set to a firm jelly which was cut into 
cubes, frozen and stored at -20' until required. 
Animals were maintained in groups of five per cage, on wire grids to minimize 
coprophagy. Animals fed on the thiamin-free diet were allowed access to food ad lib. 
Control animals received the same diet, supplemented with 10 mg thiamin hydro- 
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chloride/kg diet, and were pair-fed with the experimental group, each group receiving the 
same amount of food as an age-matched experimental group had consumed the day before. 
Animals receiving the stock diet were fed on Diet 86 (A. Dixon & Sons, Ware, Herts) 
ad lib. All animals had free access to water at all times. There was no control of day-length; 
the animal house was illuminated by a mixture of daylight and artificial light during the 
working day. 
Animals were killed by decapitation using a small-animal guillotine. Blood was collected 
into heparinized beakers on ice and centrifuged at 2000 g for 15 min. The erythrocyte 
pellet was washed by resuspension twice in the original blood volume of 0.15 mol sodium 
chloride/l, then lysed by suspension in the same volume of distilled water and frozen and 
stored for up to 1 week at -2O", until required for the determination of transketolase, as 
described later. In all cases, samples from deficient and control animals at the same time- 
point had been stored for the same length of time, and were analysed together. The brains 
were dissected out within 20 s of decapitation, frozen in liquid nitrogen and stored at - 20" 
until required for the determination of ATP, glutamate, 2-oxo-glutarate, GABA and 
thiamin, as described later. A portion of liver was dissected out within 45 s of decapitation, 
was frozen in liquid N, and stored at - 20" until required for the determination of thiamin. 
In vivo studies of brain glutainate metabolism 
Animals which had been maintained on the diets for 3 weeks from weaning were 
anaesthetized by intra-muscular injection of Hypnorm (fluanisone 10 mg and fentanyl 
citrate 0-135 mg/kg body-weight; Janssen). The skin over the skull was slit along the mid- 
line, from between the eyes to the level of the ears with a scalpel and peeled aside to reveal 
the skull. A hole was drilled through the skull using a 2 mm diameter needle at a position 
5 mm posterior to the coronal suture and 2 mm to the left of the saggital (mid-line) suture. 
A solution (10 yl) of ~-[U-l~]glutamate (50 yCi/ml, 280 Ci/mol) was then injected 
through this hole, using a Hamilton micro-syringe with a needle sharpened at an angle 
of 45", with a plastic sleeve over the needle to prevent penetration further than 3 mm 
(Waynforth, 1980). 
At 2, 5 and 10 min after the intracerebroventricular injection, animals were decapitated, 
brains were dissected out and frozen in liquid N,, within 20 s. Brain GABA and 
radioactivity in GABA were determined as described later. 
Analytical methods 
Frozen brains were bisected longitudinally. Half was homogenized while still frozen in 10 ml 
ice-cold 80 YO (by volume) ethanol/g tissue, followed by centrifugation at 25000 g for 
25 min. The resulting supernatant fraction was used for the fluorimetric determination of 
GABA after chromatographic separation on columns of Sepharose C16B and reaction with 
o-phthalaldehyde (van der Heyden & Korf, 1978; van der Heyden et al. 1979). 
The other half of each brain was homogenized while still frozen in 10 ml ice-cold 
perchloric acid (0.4 mol/l)/g tissue, followed by centrifugation at 25000 g for 30 min. The 
supernatant fraction was neutralized with potassium hydroxide (0.4 mol/l) and 1 ml tris- 
citrate buffer (1 mol/l) at pH 7.3, cooled to 4" and centrifuged at 2000 g for 20 min to 
remove potassium perchlorate. Portions of this neutralized acid extract were used for the 
determination of total thiamin, after acid phosphatase (EC 3.1 .3.2) action to hydrolyse 
phosphates to free thiamin, by the thiochrome fluorimetric method (Udenfriend, 1962) ; 
glutamate and 2-0x0-glutarate spectrophometrically using glutamate dehydrogenase 
(EC 1.4.1.2) (Bergmeyer & Bernt, 1974), and ATP spectrophometrically by the linked 
reaction of phosphoglycerate kinase (EC 2.7.2.3) and glyceraldehyde 3-phosphate 
dehydrogenase (EC 1.2.1.12) (Jaworek er al. 1974). 
For the studies of [14C]glutamate metabolism in vivo, the entire brain was homogenized 
T
ab
le
 1
. D
ev
el
op
m
en
t 
of 
th
ia
m
in
 d
ef
ic
ie
nc
y 
in
 r
at
s 
m
ai
nt
ai
ne
d 
fr
om
 w
ea
ni
ng
 o
n 
a 
th
ia
m
in
-f
re
e 
di
et
 
(V
al
ue
s a
re
 m
ea
ns
 w
ith
 t
he
ir 
st
an
da
rd
 e
rr
or
s 
fo
r 
fiv
e 
an
im
al
s 
in
 e
ac
h 
gr
ou
p)
 
Pe
rio
d 
on
 d
ie
t 
(w
ee
ks
). .
 . 
1 
2 
3 
4 
3
 
C
on
tr
ol
 
D
ef
ic
ie
nt
 
C
on
tr
ol
 
D
ef
ic
ie
nt
 
C
on
tr
ol
 
D
ef
ic
ie
nt
 
C
on
tr
ol
 
D
ef
ic
ie
nt
 
;
 
B
od
y-
w
t (
8)
 
Er
yt
hr
oc
yt
e 
tra
ns
ke
to
la
se
 
(E
C
 2
.2
.1
.1
) 
(n
m
ol
 h
ex
os
e 
fo
rm
ed
/m
in
 p
er
 m
g 
ha
em
og
lo
bi
n)
 
B
as
al
 
+T
hi
am
in
 p
yr
op
ho
sp
ha
te
 
A
ct
iv
at
io
n 
co
ef
fic
ie
nt
 
Li
ve
r 
th
ia
m
in
 (
nm
ol
/g
) 
B
ra
in
 t
hi
am
in
 (
nm
ol
/g
) 
M
ea
n 
SE
 
M
ea
n 
SE
 
M
ea
n 
SE
 
M
ea
n 
SE
 
M
ea
n 
SE
 
M
ea
n 
SE
 
M
ea
n 
SE
 
93
 
5.
4 
9.
4 
0.
92
 
9.
8 
08
8 
1.
03
 
00
67
 
11
9 
9.
43
 
nd
 
95
 
2.
6 
10
5 
4.
1 
96
 
1.7
 
13
5 
4.
1 
96
 
4.
9 
17
6 
4.
9 
6.
2*
 
0.
44
 
7.
7 
0.
66
 
4.
9 
0.
66
 
6.
4 
05
8 
2.
9*
* 
0.
42
 
nd
 
7.
2*
* 
0
3
1
 
8.
3 
06
8 
6
7
 
0.
88
 
6
9
 
1.
44
 
4.
7 
0
7
6
 
nd
 
1.
16
* 
0.
08
0 
1.
07
 
0.
08
0 
1.
36
* 
0.
10
2 
1.
08
 
0.
08
1 
1.
63
**
 
01
23
 
nd
 
22
.8
**
* 
2.
81
 
14
9 
5.
9 
11
.3
**
* 
2.
19
 
13
2 
8.2
 
6.
0*
**
 
0.
72
 
nd
 
nd
 
12
.2
 
0.
62
 
10
.4
 
0.
53
 
12
.6
 
0
6
4
 
6.
2*
**
 
0.
31
 
12
.9
 
0.
66
 
4'
 
M
ea
n 
SE
 
P
 * 
67
**
* 
4.
3 
0
 
m
 > 2 0 0 4 
nd
 
nd
 
nd
 
2 
nd
 
z 
3.
6*
**
 
0.
19
 
nd
, 
N
ot
 d
et
er
m
in
ed
. 
M
ea
n 
va
lu
es
 f
or
 c
on
tr
ol
 a
nd
 d
ef
ic
ie
nt
 a
ni
m
al
s 
at
 e
ac
h 
tim
e 
po
in
t 
in
de
pe
nd
en
tly
 w
er
e 
si
gn
ifi
ca
nt
ly
 d
iff
er
en
t 
(r
 te
st
): 
* 
0.
05
 >
 P
 >
 0
.0
1,
 
**
 0
.0
1 
>
 P
 >
 0
,0
01
, 
**
* 
P 
<
 0.
00
1.
 
B R A I N  GABA I N  T H I A M I N  D E F I C I E N C Y  249 
Table 2. Brain A TP, glutamate, 2-0x0-glutarate and y-aminobutyrate (GABA) in rats 
maintained for  3 weeks from weaning on a thiamin-free diet 
(Values are means with their standard errors for numbers of animals as shown) 
Control Thiamin-free diet 
Mean SE n Mean SE n 
ATP @mol/g) 2.8 0.085 16 2.9 0.009 17 
Glutamate @r~ol/g) 13.8 0.29 55 11.3 0.21*** 61 
GABA (umol/g) 1.67 0.046 17 1.58 0.031** 17 
.- 
2-0x0-glutarate (pmol/g) 0-14 0.006 23 009  0.007*** 21 
Mean values were significantly different from those of the control group ( t  test): ** 0.01 > P > 0.001, 
*** P < 0.001. 
in 80 YO (by volume) ethanol. GABA was determined as described previously. Radioactivity 
in GABA was determined after evaporating replicate 1 ml samples of the supernatant 
fraction to dryness, redissolving in 100 pl 50 YO (by volume) acetic acid, containing 
glutamate (1 mmol/l) and GABA (1 mmol/l), and paper chromatography of 50 p1 
portions, developed in ascending 7 vol. 95 YO (by volume) ethanol : 3 vol. ammonium 
acetate (0.1 mol/l), pH 5.0. Parallel standards of glutamate and GABA were also 
chromatographed, and their positions determined by staining with ninhydrin. Regions of 
the chromatograms containing glutamate and GABA were excised, placed in scintillation 
counter vials with 2 ml of a solution of PPO (2.5 g/l) and POPOP (0.25 g/l) in toluene, and 
radioactivity determined in a Beckman liquid scintillation spectrometer. 
The activity of transketolase in erythrocyte lysates was determined colorimetrically, with 
and without pre-incubation of the sample with thiamin pyrophosphate (20 mmol/l), as 
described by Brin (1967). Haemoglobin was determined colorimetrically by the 
cyanmethaemoglobin method (Oser, 1965). Enzyme activity was calculated as nmol hexose 
formed/min per mg haemoglobin, and also as the activation coefficient (ratio : activity after 
pre-incubation with thiamin pyrophosphate : basal activity). 
R E S U L T S  
The animals fed on the thiamin-free diet grew at the same rate as the controls during the 
first week after weaning; thereafter, as shown in Table 1, they gained no more weight, and 
during the fourth week lost 30% of their body-weight. At this time they showed signs of 
neurological damage, with arched spines and an unsteady gait. 
Both basal and thiamin pyrophosphate-stimulated transketolase activity in erythrocyte 
lysates were lower in thiamin-deficient animals than in controls ; the transketolase 
activation coefficient was significantly higher in the deficient animals. Liver total thiamin 
was considerably lower in deficient animals than in controls from the first week. Brain 
thiamin was apparently protected, not showing any significant fall until the third week, 
when it was 48% of that in control animals. By the fourth week, brain thiamin in the 
deficient animals was only 28 YO that of controls. 
As shown in Table 2, maintaining the animals for 3 weeks on the thiamin-deficient diet 
had no effect on brain ATP, but resulted in a small but significant fall in the brain 
concentrations of glutamate, 2-0x0-glutarate and GABA. The specific radioactivity of 
GABA formed after intracerebroventricular injection of [14C]glutamate (shown in Table 3) 
was significantly higher in the thiamin-deficient animals at 2, 5 and 10 min after injection. 
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Table 3. Brain y-aminobutyrate (GABA) and speclJic radioactivity in GABA after 
intracerebroventricular injection of0.5 pCi [U-'4C]glutamate, in rats maintained for 3 weeks 
from weaning on a thiamin-free diet 
(Values are means with their standard errors for numbers of animals as shown) 
~~ 
- _._ . . _______ __ 
Control Thiamin-free diet 
Period after injection (min) Mean SE n Mean SE n 
2 GABA (pnol/g) 1.57 0.087 10 1.34* 0.063 8 
Specific activity (Ci/mol) 105 8.98 10 152** 10.1 8 
5 GABA (pmol/g) 2.18 0.015 12 1.59** 0.038 6 
Specific activity (Ci/mol) 127 10.9 12 192** 10.0 6 
10 GABA (pmol/g) 2.32 0.120 7 2.05* 0,057 7 
Specific activity (Ci/mol) 61 5.1 I 89** 9.5 7 
Mean values for control and deficient animals at each time point independently were significantly different 
( t  test): * 0.05 > P > 0.01, ** 0.01 > P > 0.001. 
3'0 1 T 
2.5 
- s 
Y al z 2.0 - 
Month 
Fig. 2. Circumannual variation in brain y-aminobutyrate (GABA) in 100-g male rats maintained on animal-house 
stock diet. Points show means with their standard errors for three to six animals in each group. ---, 
Interpolation. 
During the course of the present study it was noted that while there was a consistent and 
significant reduction in brain GABA in thiamin-deficient animals compared with controls, 
there was a greater difference between groups of animals in which brain GABA was 
measured at different time intervals than between deficient and control animals investigated 
at the same time interval. The brain content of GABA was, therefore, determined in groups 
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of three to six male rats, weighing 100 g, which had been maintained from weaning on 
animal house stock diet, at intervals over 3 years. The results are shown in Fig. 2, which 
shows a clear and marked circumannual variation in brain GABA, with a peak of 2.5 
(SE 0.17) pmol/g tissue in mid-summer and a minimum concentration of 0.6 (SE 0.04) pmol/g 
tissue in mid-winter. 
D I S C U S S I O N  
The results in Table 1 show that maintenance for 3 4  weeks on a thiamin-free diet resulted 
in a significant degree of thiamin depletion, with a fall in the brain concentration of thiamin 
to 28 YO of that found in pair-fed control animals by the fourth week. 
In common with previous studies, which have demonstrated considerable impairment of 
energy-yielding metabolism at the levels of pyruvate decarboxylase, transketolase and 
2-0x0-glutarate decarboxylase (Holowack et al. 1968; McCandless & Schenker, 1968), the 
present study has shown that moderately severe thiamin deficiency has no effect on the 
concentration of ATP in the brain. Similarly, the reduction in the brain concentration of 
GABA, to 90 YO of the control value, is in agreement with other reports (Gubler et al. 1974; 
Hamel et al. 1979; Butterworth, 1983). 
Impairment of 2-0x0-glutarate decarboxylase in thiamin deficiency, reported by 
Holowack et al. (1 968), Gibson et al. (1984) and Parker et al. (1 984) to be of the order of 
50 %, would be expected to result in an increased accumulation of 2-0x0-glutarate in the 
brain. As shown in Table 2, there was however a significant reduction in brain 2-0x0- 
glutarate, to about 64% of the control level. 
As shown in Table 3, there was a significant increase in the specific activity of GABA 
formed from intracerebroventricularly injected [l*C]glutamate in the thiamin-deficient 
animals. A part of this might be attributed to the reduced pool of brain glutamate, since 
all animals received the same amount of radioactivity (0.5 pCi). However, thiamin 
deficiency had no significant effect on the weight of the brain, and there was no difference 
between the two groups of animals in the total radioactivity recovered/g of brain (values 
not shown). While the brain concentration of glutamate in the deficient animals was 
reduced by 18 YO compared with controls, the specific activity of GABA was increased by 
between 45 and 50%. The increase in the brain content of GABA after the 
intracerebroventricular injection (presumably a response to either the anaesthetic or the 
trauma of injection) was the same in both groups of animals. The results thus suggest that 
there was an increase in the rate of synthesis of GABA, and hence an increase in metabolic 
flux through the GABA shunt, in the thiamin-deficient animals. A similar increase in flux 
thorough the GABA shunt in thiamin-deficient animals can be calculated from the results 
reported by Gubler et al. (1974). While it might, therefore, be expected that the specific 
radioactivity of brain GABA would reach a peak earlier in the thiamin-deficient animals, 
with only three time points (see Table 3) it is not possible to determine rate curves. 
It is difficult to account for the observed reduction in brain 2-0x0-glutarate in the 
deficient animals, to 64% of that in the controls. Impairment of 2-0x0-glutarate 
dehydrogenase in thiamin deficiency, reported by Holowack et al. (1968), Gibson et al. 
(1984) and Parker et al. (1984) to be of the order of 50%, would be expected to result in 
increased accumulation of 2-0x0-glutarate in the brain. 2-0x0-glutarate is the preferred 
0x0-acid substrate of GABA aminotransferase (EC 2.6.1 .19), and in vitro the activity of 
the GABA shunt can be manipulated by altering the concentration of 2-0x0-glutarate 
(McKhann & Towers, 1961; Schousboe, 1981). It is likely that increased activity of 
this enzyme, coupled with increased activity of succinic semi-aldehyde dehydrogenase 
(EC 1 .2.1.24), would result in increased amination of 2-0x0-glutarate to glutamate. At 
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the same time, the increased catabolism of GABA would relieve product inhibition of 
glutamate decarboxylase (EC 4.1 . I  .15), thus resulting in increased synthesis and 
catabolism of GABA, an increased rate of metabolic flux through the GABA shunt (Hear1 
& Churchich, 1984; Porter & Martin, 1984; Porter et al. 1986). 
The marked circumannual variation in brain GABA, shown in Fig. 2, appears not to have 
been reported previously, although Rozanov (1982) has reported that in mice the brain 
GABA concentration is higher in winter than in summer, the reverse of the pattern reported 
here in rats. In reviewing circadian rhythms in neurotransmitter receptors, Wirz-Justice 
(1987) noted that all receptors that have been investigated show circadian rhythms, and 
the phase and amplitude of these rhythms often show circumannual variation, even in 
animals maintained under conditions of controlled day-length. Such circumannual effects 
are reported to vary widely between species, between different strains of the same species, 
and even between different breeding colonies of the same species (Wirz-Justice, 1987). In 
the present study there was no control of day-length; the animals were exposed to varying 
natural light, as well as artificial light during the working day. The animals were Wistar rats 
from a breeding colony maintained in the Courtauld Institute of Biochemistry of the 
Middlesex Hospital Medical School, into which there had been no introductions for many 
years. All animals were killed at about the same time of day, between 09.30 and 11.00 
hours. 
The studies reported in Tables 2 and 3 were all performed between February-April and 
September-November, equivalent periods in the circumannual variation in brain GABA 
shown in Fig. 2. Similar studies were performed at  other times of the year. Although the 
results showed a significantly different concentration of GABA in the brains of control 
animals, as would be expected from the circumannual variation shown in Fig. 2, there was 
consistently a significant difference between thiamin-deficient and control animals, of the 
same order of magnitude as that shown in Table 2. 
The present study has thus demonstrated that in thiamin deficiency there is an apparent 
increase in the rate of synthesis of GABA from glutamate, indicative of an increased rate 
of metabolic flux through the GABA shunt, suggesting that this pathway can indeed 
provide an alternative to the thiamin-dependent oxidative decarboxylation of 2-0x0- 
glutarate, to maintain energy-yielding metabolism in thiamin deficiency. 
Increased metabolic flux through GABA may explain the well-established anorexia 
associated with thiamin deficiency. In experimental animals, increased GABA flux in the 
ventro-lateral hypothalamus inhibits feeding (Kimura & Kuriyama, 1975 ; Kasser et ul. 
1985). A relatively specific inhibitor of GABA aminotransferase, 1 -(n-decyl)-3-pyrazolidine, 
which causes a threefold increase in brain GABA content in rats, causes marked anorexia 
(White et al. 1982). 
M.G.P. was an SERC student; V.A.-S. was supported by the British Council and the 
Government of Ghana. 
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